A meta-analysis has demonstrated that CTNNB1 mutations significantly increase the odds of tumor recurrence and correlate with worse disease-free survival among patients lacking a specific molecular profile (NSMP) [51]. The gene discussed is CTNNB1; the disease is neoplasm.